Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 15, 2015 - Issue 5
Submit an article Journal homepage
128
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Natalizumab in spinal multiple sclerosis in a daily clinical setting

Chiara ZeccaDepartment of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Via Tesserete 46, CH-6903 Lugano, Switzerland+41 91 811 6921; +41 91 811 6915; [email protected]
, MD,
Mirjam R HeldnerBern University Hospital and University of Bern, Department of Neurology, Inselspital, Bern, Switzerland
, MD,
Christian P KammBern University Hospital and University of Bern, Department of Neurology, Inselspital, Bern, Switzerland
, MD,
Gianna C RiccitelliDepartment of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Via Tesserete 46, CH-6903 Lugano, Switzerland+41 91 811 6921; +41 91 811 6915; [email protected];Vita-Salute San Raffaele University, Institute of Experimental Neurology, Neuroimaging Research Unit, Milan, Italy
, PhD,
Giulio DisantoDepartment of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Via Tesserete 46, CH-6903 Lugano, Switzerland+41 91 811 6921; +41 91 811 6915; [email protected]
, MD, PhD,
Matteo CaporroDepartment of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Via Tesserete 46, CH-6903 Lugano, Switzerland+41 91 811 6921; +41 91 811 6915; [email protected]
, MD,
Alessandro CianfoniNeuroradiology Department, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland
, MD,
Emanuele PravatàNeuroradiology Department, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland
, MD &
Claudio GobbiDepartment of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Via Tesserete 46, CH-6903 Lugano, Switzerland+41 91 811 6921; +41 91 811 6915; [email protected]
, PD, MD show all
Pages 633-640 | Published online: 03 Apr 2015

Bibliography

  • Polman CH, O’Connor PW, Havrdova E, et al. (AFFIRM Investigators). A randomized, placebo controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006;354:899-910
  • Rudick RA, Stuart WH, Calabresi PA, et al. (SENTINEL Investigators). Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 2006;354:911-23
  • Holmén C, Piehl F, Hillert J, et al. A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. Mult Scler 2011;17:708-19
  • Langer-Gould A, Popat RA, Huang SM, et al. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol 2006;63:1686-91
  • Mowry EM, Deen S, Malikova I, et al. The onset location of multiple sclerosis predicts the location of subsequent relapses. JNNP 2009;80:400-3
  • Barcellos LF, Oksenberg JR, Green AJ, et al. (Multiple Sclerosis Genetics Group). Genetic basis for clinical expression in multiple sclerosis. Brain 2002;125:150-8
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52
  • Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302
  • Sombekke MH, Wattjes MP, Balk LJ, et al. Spinal cord lesions in patients with clinically isolated syndrome. A powerful tool in diagnosis and prognosis. Neurology 2013;80:69-75
  • Coret F, Bosca I, Landete L, et al. Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing-remitting multiple sclerosis. Mult Scler 2010;16:935-41
  • Kleiter I, Hellwig K, Berthele A, et al. (Neuromyelitis Optica Study Group, NEMOS). Is it too early to predict the failure of natalizumab in NMO?-Reply. Arch Neurol 2012;69:1085-6
  • Freedman MS, Patry DG, Grand’Maison F, et al. (Canadian MS Working Group). Treatment optimization in multiple sclerosis. Can J Neurol Sci 2004;31:157-68
  • Rudick RA, Lee JC, Simon J, et al. Defining interferon beta response status in multiple sclerosis patients. Ann Neurol 2004;56:548-55
  • Río J, Castilló J, Rovira A, et al. Measures in the first year of therapy predict the response to interferon beta in MS. Multiple Sclerosis 2009;15:848-53
  • Sormani MP, Li DK, Bruzzi P, et al. Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis. Neurology 2011;77:1684-90
  • Wang YC, Sandrock A, Richert JR, et al. Short-term relapse quantitation as a fully surrogate endpoint for long-term sustained progression of disability in rrms patients treated with natalizumab. Neurol Res Int 2011;2011:195831
  • Okuda DT, Mowry EM, Cree BA, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 2010;76:686-92
  • Minneboo A, Barkhof F, Polman CH, et al. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004;61:217-21
  • Tintore M, Rovira A, Arrambide G, et al. Brainstem lesions in clinically isolated syndromes. Neurology 2010;75:1933-8
  • Swanton JK, Fernando KT, Dalton CM, et al. Early MRI in optic neuritis: the risk for disability. Neurology 2009;72:542-50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.